Takashi Morimoto

发表

Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil–epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy

H. Sasano, N. Masuda, H. Yamashita, 2013, Breast Cancer Research and Treatment.